A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome

NCT05690386 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Turner Syndrome

Interventions

BIOLOGICAL: Lonapegsomatropin
DRUG: Somatropin

Sponsor

Ascendis Pharma Endocrinology Division A/S